CMR Surgical is developing next-generation robotic systems for minimal access surgery.
- CMR Surgical is developing a next-generation surgical robot
- Announces a fundraise of £100 million in 2018, then the largest ever Series B funding round for private European medtech company
£100 millionSeries B fundraise in 2018
- Develop and execute an international profile raising strategy in order to create maximum impact of the news
- Significant media coverage across international business media and trade publications including the Financial Times, The Times and The Telegraph
More case studies
Immunocore is a leading T cell receptor (TCR) company developing biological drugs to treat cancer, infectious diseases and autoimmune diseases, through its pioneering soluble TCR technology platform.
Quanta is a medical device company providing innovative haemodialysis solutions for the clinic and the home.
Vectura is an industry-leading device & formulation business for inhaled airways disease.